We were always called in late. So we built the answer in advance.

qointa exists because the question "is this device regulated, and what does that mean for us?" was always asked after the protocol was written — and answering it consistently turned out to be a framework, not a favour.

We built the framework because we kept being asked the same question late

Sponsors did not come to us asking for a governance model. They came late, with a device already chosen, a protocol already written, and a question that should have been answered months earlier: is this thing regulated, and what does that mean for us?

Answering it once is consulting. Answering it the same way every time, so the reasoning holds when a different person asks two years later, is a framework. That is what qointa became.

Quality is in the name, not the marketing

qointa stands for Quality Observations In Treatment Assets. It describes the work literally: the observations a treatment asset produces are only worth what the quality system around them can demonstrate. A measurement no one can defend is not evidence.

We have sat on both sides of the table

Our people have run trials inside sponsors and delivered technology into them as vendors. We have written the requirements and we have been audited against them. That matters more than it sounds: most compliance advice fails not because it is wrong, but because it is unimplementable by the team that has to live with it.

It is also why we do not sell a deck. An engagement produces controlled artefacts you keep — a recorded decision per perimeter, the reasoning behind it, and the register of what would change the answer.

We publish our reasoning

The framework is documented rather than asserted. The position papers and whitepapers in our library set out how we qualify a device, how we classify a mid-study change, and where the frameworks contradict each other at the edges. You can read the method and judge it before you engage us — which is the point.

What we are not

We are not a generalist quality consultancy that also does digital, and we are not a staffing firm. We work on digital health technologies in regulated research, and when a request sits outside that, we say so and point elsewhere. A specialist who takes everything is not a specialist.

Read the thinking behind this

Our regulatory position papers and whitepapers. Three download without an account; a free account opens the rest.

The qointa brochure BrochuresFree

The qointa brochure

The qointa brochure in print format: what we do, for whom, and how an engagement runs.

Download PDF →
Digital Health Technologies in Clinical Trials — A Regulatory Position-Paper Series Position papers

Digital Health Technologies in Clinical Trials — A Regulatory Position-Paper Series

One device, several perimeters: a framework for assessing the regulatory impact of the technologies a trial relies on.

Sign in to download →
Digital Trials and the Device Perimeter: A Regulatory Primer Position papersFree

Digital Trials and the Device Perimeter: A Regulatory Primer

A plain-language entry point to the regulatory questions raised by the devices and systems a clinical trial relies on — wearables and sensors, home and point-of-care instruments, apps and eCOA platforms, clinical systems, and the phones and tablets that connect them

Download PDF →

All papers in the library →

Ask us the question early

Bring one device and one protocol. We will tell you which perimeters it opens and what it takes to close them.

Book a 15-minute call